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Abstract
Background: The Health Improvement and Prevention Study (HIPS) study aims to evaluate the capacity of general
practice to identify patients at high risk for developing vascular disease and to reduce their risk of vascular disease
and diabetes through behavioural interventions delivered in general practice and by the local primary care
organization.
Methods/Design: HIPS is a stratified randomized controlled trial involving 30 general practices in NSW, Australia.
Practices are randomly allocated to an ‘intervention’ or ‘control’ group. General practitioners (GPs) and practice
nurses (PNs) are offered training in lifestyle counselling and motivational interviewing as well as practice visits and
patient educational resources. Patients enrolled in the trial present for a health check in which the GP and PN
provide brief lifestyle counselling based on the 5As model (ask, assess, advise, assist, and arrange) and refer high
risk patients to a diet education and physical activity program. The program consists of two individual visits with a
dietician or exercise physiologist and four group sessions, after which patients are followed up by the GP or PN. In
each practice 160 eligible patients aged between 40 and 64 years are invited to participate in the study, with the
expectation that 40 will be eligible and willing to participate. Evaluation data collection consists of (1) a practice
questionnaire, (2) GP and PN questionnaires to assess preventive care attitudes and practices, (3) patient
questionnaire to assess self-reported lifestyle behaviours and readiness to change, (4) physical assessment including
weight, height, body mass index (BMI), waist circumference and blood pressure, (5) a fasting blood test for glucose
and lipids, (6) a clinical record audit, and (7) qualitative data collection. All measures are collected at baseline and
12 months except the patient questionnaire which is also collected at 6 months. Study outcomes before and after
the intervention is compared between intervention and control groups after adjusting for baseline differences and
clustering at the level of the practice.
Discussion: This study will provide evidence of the effectiveness of a primary care intervention to reduce the risk
of cardiovascular disease and diabetes in general practice patients. It will inform current policies and programs
designed to prevent these conditions in Australian primary health care.
Trial Registration: ACTRN12607000423415
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Background
The prevention and treatment of cardiovascular disease
are major challenges confronting the community and
the health system in Australia and internationally [1].
Given the contribution of cardiovascular disease to dis-
ease burden, the cost of inadequate prevention is high
[2]. Diabetes, itself a major risk factor for ischaemic
heart disease and stroke, affects 7.5% of Australians, and
a further 16.3% of the population over the age of 25
years have impaired glucose metabolism [3].
There is considerable evidence for the effectiveness of
interventions to prevent cardiovascular disease at the
population and individual levels [4]. A simple office-
based lifestyle intervention has been shown to signifi-
cantly reduce total cholesterol in hypercholestrolaemic
patients [5]. Intensive lifestyle interventions involving
diet and exercise have also been shown to be effective in
the prevention of diabetes in patients with impaired glu-
cose tolerance and also lowering blood pressure in
patients with hypertension over 6 months [5-8]. Even
moderate reductions in weight has been shown to
reduce the incidence of diabetes by more than one half
[7-9]. Studies such as these suggest that there is a strong
case for intervening in groups at high risk of developing
lifestylerelated disease [10].
The Australian national health survey 2007-2008
found that the most common vascular risk factors were
those related to nutrition, with over 90% of adults not
meeting the recommended serves of vegetables, over
half not consuming adequate amounts of fruit and 62%
being overweight or obese [11]. Around one third of
adults were classified as physically inactive, one in five
smoked, and of the 59% of the population who drank
alcohol, 21% did so at a level which would pose a risk
to their health [11]. Patients who already have one or
more risk factors for vascular disease may be more likely
to perceive potential health risk, as well as benefits, than
those who are not at risk. This may increase their moti-
vation to participate in lifestyle change activities [12].
However, advice about risk may also increase psycholo-
gical distress [13] which in turn can also impact on
behaviour choices [14].
General practice is well placed to offer early interven-
tions to modify lifestyle risk factors. It provides care
across the continuum from prevention of illness to
treatment and rehabilitation, and provides consultations
to approximately 90% of Australians each year [15]. In
2007-08, 59% of general practice encounters were with
patients who were overweight or obese, 26% with those
who drank alcohol at risky levels and 17% with those
who smoked daily [16]. There is evidence that lifestyle
modification can be implemented in general practice
and that selective interventions can bring about
behaviour change in patients [17-19]. However, many
studies have focused on single risk factors and have not
tried to change systematically. Findings from research
into interventions that have targeted multiple factors
have been more equivocal [20].
Few primary care encounters in Australia involve risk-
factor assessment and intervention, signifying an impor-
tant gap between evidence and practice [21]. The chal-
lenge is thus to determine if interventions outside the
practice can be integrated with routine clinical care in
Australian general practice. Our previous research and
that of others suggests that referral of high risk patients
to services to support lifestyle change is infrequent
[22-24].
General practice preventive care in Australia has
recently been enhanced by the introduction of health
checks. A “Well Person’s Health Check” in general prac-
tice for people aged 45-49 was introduced in November
2006, as a once-only service for those who have one or
more identifiable risk factors for chronic disease [25]. In
2008 a diabetes risk check was introduced for patients
aged 40-49 which aimed to identify patients at high risk
for diabetes, to introduce lifestyle interventions.
Although these checks have been taken up by GPs, the
referral rate of high risk patients for more intensive life-
style interventions has been disappointingly low [26].
Study Aim and Hypotheses
The aim of the HIPS is to evaluate the impact of a gen-
eral practice intervention for patients at high risk of
vascular disease on changes in behavioural and physiolo-
gical risk factors (Table 1).
Methods/Design
The HIPS is a cluster-randomised controlled trial with
randomisation at the practice level, conducted in general
practice in the state of New South Wales (NSW),
Australia.
Recruitment
Recruitment of Divisions of General Practice and Practices
In Australia, general practice is supported by regional
organizations known as Divisions General Practice
(DGPs), part of whose role is to work with practices to
improve their quality of care. This study involves three
urban and two rural DGPs in NSW, which invited prac-
tices to participate in the study. Practices are identified
from databases held at the DGP and are invited to parti-
cipate in the study via a letter from the Division. Each
DGP is asked to recruit eight practices to participate in
the study (two of the urban DGPs participate as a pair,
each aiming to recruit four practices). General practices
are eligible to participate if they use computer-based
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medical records, are not involved in other research, and
are located in the participating DGPs. All GPs and PNs
in participating practices are invited to take part in the
study (Figure 1).
Recruitment of Patients
Participating practices are asked to search their electronic
records to identify a list of 160 patients who meet the
selection criteria (Table 2). Previous research suggests
that 25% of these will be eligible and willing to partici-
pate. The rationale for the eligibility criteria is to recruit
sufficient patients with high to moderate risk of cardio-
vascular disease or diabetes to participate in the full
intervention (both in general practice and the referral
program). Patients in the 40-55 age groups are targeted
by existing health checks but are less likely to have multi-
ple risk factors or to be at high CVD or diabetes risk.
Thus in this age group we are specifically targeting those
who already have physiological risk factors. Patients aged
56-64 are more likely to have multiple risk factors and
also to be at increased risk because of their age. The
majority of general practice patients older than 64 years
have already developed a chronic disease.
Up to 160 eligible patients are sent a letter from the
practice, signed by their GP, advising that the practice is
participating in the research and that the patient has
been randomly selected to be invited to participate (if the
list exceeds 160 patients, 160 are randomly selected for
recruitment). An information sheet, consent form, ques-
tionnaires and a stamped envelope addressed to the pro-
ject coordinator are also included. Patients are asked to
read the information, sign the consent forms, complete
the questionnaires, and return them if they wish to take
part (Figure 1). When patients consent to participate, a
letter of invitation to attend their GP for a health check
and blood test form is mailed to them. The cost of the
blood test and the GP visit is reimbursed by the study.
Randomisation and Blinding
After baseline data collection, the 30 practices are ran-
domly allocated in variable blocks (stratified by DGP) to
‘intervention’ or ‘control’ groups by a person indepen-
dent of the research team using computer generated
random numbers. Staff involved in the data collection
are independent of those involved in the intervention
and are not informed which practices are randomized to
intervention or control groups.
Intervention
The main aim of the intervention is to assist high risk
patients to make positive lifestyle changes through sup-
porting self-management knowledge and skills, provid-
ing social support and increasing self-efficacy. At the
practice level, this includes training practice staff in
assessing risk factors and motivational interviewing
using simulated consultations with actors and practice
support. Patient education resources include resources
from the Lifescripts program [27], patient waiting room
questionnaires, a Health check visit guide, a checklist
for GPs to complete when they see patients, and a food
diary (patients are asked to fill out 3-4 days of their
diary intake each week, including at least one weekend
day, in the Daily Living Diary provided).
At the patient level, the goals of intervention are based
on those used in previous diabetes prevention studies,
including the U.S. Diabetes Prevention Program (DPP)
and the Finnish Diabetes Prevention Study (DPS) [6,7,9]
(Table 3).
GP/PN brief intervention
This intervention is modelled on previous research con-
ducted by the investigators, called SNAP (Smoking,
Nutrition, Alcohol, Physical activity) interventions in
general practice [22], and evaluation of the 45-49 year
health check [28]. The aim is to develop a brief inter-
vention that can be carried out by busy GPs and their
practice staff at the time of a “health check” such as
that currently supported for patients aged 45-49 years
[29] (Table 4). The key theoretical underpinning for the
GP intervention is the Trans-theoretical (Stages of
Change) Model which focuses on the assessment of
patient readiness to change and stage-based tailoring of
Table 1 Study hypotheses
Primary Hypotheses Secondary Hypotheses
1. In the intervention group 20% more patients who are at high risk of
developing vascular disease will be offered evidence-based interventions
(motivational counselling or referral to appropriate services) to modify
their risk factors compared with patients in the control group.
4 Patients in the intervention group will be more likely to progress in
their stage of change compared with the control group.
2 In the intervention group the self-reported attitudes and practices of
general practice staff towards preventive care and behavioural risk factor
management will improve compared with the control group
5 In the intervention group, a lower proportion of patients with high
psychological distress (K10 score > 15) will change their behaviour
compared to those who have low psychological distress (K10 score < 15)
3 The behavioural (diet, physical activity, smoking and alcohol) and
physiological (weight, LDL cholesterol, blood pressure) risk factor scores
of patients identified at high risk in the intervention group will be
reduced over 12 months in comparison with high risk patients in the
control group.
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Practice visit
Arrange a meeting with practice 
staff.  Explain study to all staff. 
Provide appropriate forms.  
GPs and PN to complete 
Consent forms and 
questionnaires
Train PLP in the study 
procedure.
Assist PLP to generate randomly selected patient list.  Identify all patients 
matching HIPS criteria, using .excel macros program. Document the 
number of patients in each list
Give the list to the GPs to confirm diagnosis and exclude unsuitable 
patients. Document the reason for exclusion 
Pre practice visit
Contact the Practice Liaison Person (PLP) to: 
Arrange with the practice manager/principal GP the date of visit 1 
Send the pre-practice visit questionnaire for completion and return  
Send GPs and PN consent form and questionnaires – to fill in and return 
Practices are randomized 
Patients receive the package 
and return the questionnaire and consent form 
Figure 1 HIPS Recruitment Flowchart.
Table 2 Patient selection criteria
Inclusion criteria
• Aged 40-55 with hypertension and/or hyperlipidaemia
• Aged 56-64
• Attended the practice in the last 12 months
Exclusion criteria by
practice
Exclusion criteria by GP
Diagnosed or treated for: • Has current severe illness or personal circumstances which are of overriding concern;
• Diabetes
• Cardiovascular disease • Is deceased (up to date medical records generally prevent this)
• Renal disease • Is no longer a patient of the practice;
• Stroke • Is unable to speak adequate English;
• Has diabetes or cardiovascular disease;
• Is unlikely to be able to read and understand the information sheet and consent form because of significant cognitive
impairment (e.g. dementia.)
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brief behavioural counselling [30]. This is applied within
the framework of the 5As model [31] (Table 5). A broad
definition of high risk (Table 6) is used (presence of a
physiological risk factor, overweight or smoking).
Development of the Intervention Program for High Risk
Patients
Individual lifestyle sessions Patients at high risk are
asked to attend an initial visit, at which an allied health
practitioner (AHP) reviews their food diary and negoti-
ates individual dietary and physical activity goals with
the patient. A follow-up visit with the AHP is arranged
at around 8-9 weeks to review progress and negotiate
additional dietary and physical activity goals.
Group Lifestyle Education - CHANGE for HIPS After
attending the AHP, patients are enrolled the CHANGE
for HIPS, This is a group education program, which is
adapted from the group component of the “Counter-
weight Program - CHANGE“ in the UK [32]. An inter-
vention officer (IO) from the local DGP is trained to
facilitate this program and provided with the required
resources. CHANGE for HIPS consists of four group ses-
sions (1.5 hours each) over the first three months and a
further two follow-up sessions at six and nine months.
The group sessions include an educational and physical
activity component (20-30 minutes of walking or resis-
tance exercise) and are based on the use of self-manage-
ment strategies (goal setting, selfmonitoring, and
developing practical skills and problem solving to
promote positive dietary and physical activity changes
and weight loss) (Figure 2). Between sessions patients
keep a food and physical activity diary, use a pedometer
and carry out home-based physical activity.
Quality assurance
The quality of the intervention process is monitored by
an Intervention Advisory Committee It includes evalua-
tion of the GP/PN training sessions, evaluation of group
sessions in each DGP, record of practice visits kept by
IOs and ongoing feedback by practice staff on the inter-
vention, and evaluation of patients’ feedback on group
sessions.
Usual care
Patients attending the control practices receive usual
general practice care of their risk factors. After the sec-
ond data collection at 12 months, the HIPS GP/PN
training is offered to GPs in those practices.
Data collection
Data are collected at baseline, 6 months and 12 months
from administrative staff, GPs, PNs, and patients. The
questionnaires take between 10-30 minutes to complete
(Table 7). These questionnaires have been piloted before
their use in the trial.
Sample size calculation
All sample size calculations use a significance level of
5% and power of 80%, with design effects and estimated
expected differences between the intervention and con-
trol groups based on previous research
Evidence-based intervention provided to patients
Assuming a design effect due to clustering of 2 based
on previous studies [30-33], a sample of 188 patients in
each group will detect a 20% difference in the propor-
tion of patients offered evidence-based interventions
(motivational counselling or referral to appropriate ser-
vices) to modify their risk factors, compared to the con-
trol group.
Reduction in physiological risk factors Assuming a
design effect due to clustering of 1.8, loss to follow up
Table 3 HIPS intervention goals
Intervention Goals
Exercise • Moderate exercise for at least 30 minutes/day, including walking, jogging, swimming, aerobics, ball games, or skiing with
circuit-type resistance training, twice a week.
Diet • Diet low in saturated fats, sucrose and salt with increased portions of vegetables and fruit per day (up to 7 portions) in order to
achieve a diet with the percentage of energy from carbohydrate = 50%, saturated fat < 10% and total fat < 30%, protein 1 g/kg
ideal body weight per day, fibre 15 g/1000 kcal.
Weight
reduction
• (if overweight) of ≥ 5 kg or 5% of body weight
Smoking
cessation
• if smoker
Limit alcohol
intake
• (if drinking) to ≤ 2 drinks/day, including 1-2 alcohol free days/Week
Table 4 HIPS Health Check Visit
Health Check Visit - checklist
• SNAP lifestyle risk factor assessment and assessment for previous GDM
• Review of pathology reports (lipids, fasting glucose) and/or ordering of
these
• Physical assessment (weight, height, BMI, waist circumference)
• Assessment of readiness to change
• Interventions offered (education, medication change)
• Referral of high risk patients for nutrition/physical activity program
• Follow up visit with GP at about 10 - 12 weeks
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of 20% and standard deviations based on data from gen-
eral practice diabetes registers [34]:
• weight: assuming a standard deviation of 19, a
sample size of 382 will be sufficient to detect a
mean difference of 4 Kg in weight between interven-
tion and control groups.
• LDL cholesterol: assuming a standard deviation of
0.9, a sample size of 342 will be sufficient to detect a
mean difference of 0.2 mmol/L in LDL-cholesterol
between intervention and control groups.
• blood pressure: assuming a standard deviation of
11, a sample size of 228 will be sufficient to detect a
mean difference of 3 mmHg in systolic blood pres-
sure between intervention and control groups.
Reduction in behavioural risk factors Assuming a
design effect due to clustering of 1.8 and a 20% loss to
follow up with estimates based on previous research
[35]:
• if patients eat a standard deviation 2.1 portions of
fruit and vegetables a sample of 288 in each group
would have sufficient power to detect a mean 0.5
portion difference.
• if 22% smoke, a sample of 363 in each group
would have sufficient power to detect a 6%
difference.
• if 30% consume alcohol at risk levels, a sample of
362 in each group would have sufficient power to
detect a 7% difference.
• For physical activity, a score of 2.1 in a sample of
305 in each group would have sufficient power to
detect a mean 0.5 score difference.
We aim to recruit 30 general practices and identify 160
patients from each practice (total = 4800). From this we
anticipate 25% responses in each group (600 patients in
each group). An estimated 20% loss to follow-up will
leave 480 patients in each group, of which we estimate
60% are high risk (288 patients in each group) (Figure 3).
Data Analysis
Quantitative evaluation - statistical analysis
Quantitative data analysis will be conducted using SPSS
and ML-Win (Multilevel statistics for Windows). Multi-
level linear models will be used for continuous response
variables and multilevel logistic models for binary
responses. Co-variates will be included in the analyses
to adjust for baseline differences between the interven-
tion and control groups.
The analysis will include changes in the study vari-
ables before and after the intervention in both interven-
tion and control groups, including changes in patients’
lifestyle risk factors and comparison of outcomes at 12
months between the intervention and control groups
after adjusting for baseline differences.
Qualitative evaluation
As this is a complex intervention delivered within the
context of normal practice, a qualitative evaluation of
the implementation process is important in interpreting
Table 6 Definition of high risk patient
Definition of High Risk patient
High risk patients are defined as those with any of the following characteristics:
• have history of gestational diabetes (GDM)
• have ‘Pre diabetes’ - (impaired glucose tolerance or impaired fasting glycaemia)
• have elevated blood pressure (BP ≥ 140/90 on two occasions) or on treatment for high blood pressure
• have high Lipid: Total Cholesterol (TC) > 4.5 mmol/L or Low Density Lipoprotein (LDL) > 2.5 mmol/L or Triglyceride (TG) > 2.0 mmol/L or on
treatment for it
• are overweight: BMI > 28 or waist circumference > 102 cm in males and 88 cm in females
• currently smoke.
Table 5 5As model
Ask Identification of eligible patients who are 40-64 years from practice records with invitation to attend the practice for a health check
following a blood test for fasting glucose and lipids. Completion of a waiting room questionnaire by patients on their risk factors
Assess Assessment of behavioural and physiological risk factors and readiness to change
Advise Brief advice using written materials (lifescript resources)
Assist Motivational counselling and medications if appropriate
Arrange Referral of high risk patients who are unsure or are ready to change to an allied health provider (either an exercise physiologist or a
dietician) for individual advice and goal setting; and to the CHANGE for HIPS group program. Prior to attending the program patients are
asked to complete a food diary. Follow up is arranged with the GP at about 10 - 12 weeks.
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Group Session 1 (weeks 3-4)
Introduction
Healthy lifestyle targets 
Readiness to change
Goal setting 
Self-monitoring 
Dealing with lapses
Pedometer and group walk
Group Session 2 (weeks 5-6)
Nutrition
Healthy eating principles
Energy balance
Cooking and eating out
Group resistance exercise
Group Session 3 (weeks 7-8)
Food Labels and Active Living
Shopping & nutrition label reading
Barriers to physical activity
Physical activity and strategies
Local physical activity options
Group walk
Group Session 4 (weeks 10-12)
Eating Behaviours
Review of changes
Trigger to eating & behavioural
management
Social pressures
Reshaping negative thoughts
Maintaining changes and lapse 
management
Review sessions 5 & 6 (6 & 9 months)
Review of changes and sharing of 
experiences
Relapse management
Figure 2 CHANGE for HIPS.
Table 7 Study instruments
Measurement Details Timeframe
Practice
questionnaire
(PPVQ)
• Practice capacity for preventive care including use of patient education materials, staff roles and
teamwork in preventive care, and linkages between the practice and support services
Baseline
GP/PN survey • This survey is based on questions from the Preventive Medicine Attitudes and Activities
Questionnaire (PMAAQ) [38], and the Vascular Interventions Survey [39]
Baseline & 12 Month
Patient’s survey • This survey is based on the NSW Health Survey and previous research [40,41]. It includes
questions about: (1) Practice attendance; (2) reported assessment and management of SNAP risk
factors; (3) attendances at other services as a result of referral from the practice or self-referral; (4)
self-reported fruit and vegetable intake, smoking, physical activity and alcohol intake, and attempts
to change these; (5) readiness for behaviour change (stage of change) for each SNAP risk factor
[42]; (6) The Kessler Psychological Distress Scale (K-10), a ten item questionnaire measuring negative
emotional states in the preceding four weeks [43]; (7) The Neuroticism Scale from the Eysenck
Personality Questionnaire Revised, Short form (EPQ-N-RS) [44], which represents an individual’s
tendency to experience psychological distress or neuroticism; (8) satisfaction with their care, using
the General Practice Assessment Questionnaire (GPAQ) which includes questions in relation to
satisfaction with GP and AHP visit and health check [45]
Baseline & 6 months
& 12 month
Patient’s physical
assessment
• Includes weight, height, BMI, waist circumference and blood pressure measurement.
Patient’s fasting
blood tests
• Patients are asked to have a fasting blood test to assess their serum lipids (total cholesterol, HDL,
LDL, triglycerides) and glucose.
Baseline & 12 month
Clinical record
audit
• Patient records are examined to determine recorded weight, waist circumference, blood pressure,
practice attendances during the 12 months of the trial, referral to interventions to address risk
factors identified, prescribing of medications (lipid lowering and antihypertensive medications),
referrals to dietician, exercise and smoking cessation program.
12 month
GP/PN & IOs
interviews
• Qualitative interviews are conducted with GPs and PNs in the intervention group and with IOs to
explore experience of implementing SNAP risk factor management in routine practice, feasibility
and acceptability of brief lifestyle intervention, as well as acceptability and usefulness of referral to
support services.
12 month
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the study findings [36]. Semi-structured interviews will
be conducted with intervention GPs, PNs and IOs to
explore their views on (a) the CHANGE for HIPS inter-
vention program, (b) experiences of implementation
(including feasibility, barriers and facilitators), (c) per-
ceptions of patients’ views/experiences of participation
and (d) key lessons for dissemination of the program
into routine service provision. All interviews will be
transcribed verbatim and subject to thematic analysis
using NVivo 8 [37] to identify convergence and diver-
gence of themes.
Pilot Study
All procedures and tools used in the study have been
pilot tested with a practice in a nonparticipating DGP.
Ethics
The project has been approved by the University of New
South Wales Human Research Ethics Committee
(HREC).
Discussion
Much of the focus in general practice primary preven-
tive care has been on assessment of risk, use of medica-
tions, and brief interventions to address single risk
factors. While trials have demonstrated the effectiveness
of intense interventions to prevent diabetes or cardio-
vascular disease, it has been difficult to replicate this
within routine practice. This is one of the first studies
in Australia to evaluate an intervention which includes
assessment and brief intervention in routine general
Randomisation of the practices
Intervention Group Control Group
160 patients from 30 practices = 4800
25% responses = 1200 patients
Baseline 
600 patients (360 high risk)
Baseline 
600 patients (360 high risk)
120 loss to
follow up
120 loss to
follow up
12 months 
480 patients (288 high risk)
12 months 
480 patients (288 high risk)
Figure 3 Predicted patient recruitment.
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practice coupled with a more intensive referral-based
intervention based in the local DGP. The trial is unique
in that the intervention is delivered as part of routine
practice (both in general practices and the DGP), and
the study aims to examine its impact in both high and
low risk patients. The study will also provide valuable
qualitative data on the barriers and facilitators to imple-
menting brief intervention and referral of high risk
patients to more intensive intervention in the general
practice setting.
The study involved a strong collaborative partnership
with DGPs and non-government organizations such as
the National Heart Foundation. These relationships are
essential not only to recruit participants into the study
but also to deliver an effective intervention and subse-
quently implement the findings.
The results of this study will help inform improve-
ments to the implementation of primary prevention of
vascular disease and inform the implementation of other
preventive health initiatives which involve referral to
group programs outside general practice, such as the
45-year-old health check and the diabetes risk assess-
ment in Australian general practice. The findings of the
study will be disseminated using peer-reviewed journals,
conference presentations, and research summaries tai-
lored for practitioners, service managers and policy
makers. We anticipate that it will inform broader poli-
cies and strategies including:
• defining the optimal roles of general practice staff,
allied health providers and group referral programs
in providing interventions for low and high risk
patients
• redesigning the pathways for referral and follow up
of high risk patients
• providing more effective support for primary pre-
vention through DGPs in general practice;
• redesigning the Medicare Benefits Schedule (MBS)
preventive care related item numbers;
• integrating the complex preventive interventions
required to prevent chronic diseases such as diabetes
within routine general practice and its associated
services and programs.
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